In summary, we identified the HIF-1α-mediated induction of ABCB4 as a mechanism for effluxing [18F]-D4-FCHP species within hypoxic tumours, with implications for the use of [18F]-D4-FCH and other radiolabelled choline species for monitoring the anticancer therapy response. This evidence concerns the gene HIF1A and neoplasm.